This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 5 CIPO patents and 2 EPO patents. Top assignees: Deutsches Krebsforschungszentrum, Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts, Ruprecht-Karls-Universitat Heidelberg. Active years: 2005-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 159 
1 out of 168 
1 out of 64 
Years Active: 2005-2019
Title: Innovations and Contributions of Hans-Christian Kliem
Introduction
Hans-Christian Kliem is a notable inventor based in Heppenheim, Germany. He has made significant contributions to the field of radiopharmaceuticals, particularly in the treatment and imaging of prostate cancer. With a total of 2 patents, Kliem's work has advanced the understanding and application of medical imaging agents.
Latest Patents
Kliem's latest patents include innovative methods and compounds that have the potential to revolutionize prostate cancer treatment. One of his patents focuses on labeled inhibitors of prostate-specific membrane antigen (PSMA), which are utilized as imaging agents and pharmaceutical agents for treating prostate cancer. This invention relates to the field of radiopharmaceuticals and their application in nuclear medicine, specifically as tracers and imaging agents for various disease states of prostate cancer. The compounds are represented by the general Formulae (Ia) or (Ib). Another significant patent involves a method for producing water-soluble saccharide conjugates and saccharide mimetics through the Diels-Alder reaction. This method allows for the easy preparation of saccharide compounds, streamlining the process for researchers and medical professionals.
Career Highlights
Throughout his career, Kliem has worked with prestigious institutions, including the Deutsches Krebsforschungszentrum and Ruprecht-Karls-Universität Heidelberg. His work in these organizations has contributed to the advancement of cancer research and treatment methodologies.
Collaborations
Kliem has collaborated with notable colleagues such as Matthias Eder and Klaus Kopka. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.
Conclusion
Hans-Christian Kliem's contributions to the field of radiopharmaceuticals and his innovative patents highlight his role as a significant inventor in medical science. His work continues to impact the treatment of prostate cancer and the development of imaging agents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile